Skip to main content
Premium Trial:

Request an Annual Quote

Cyclica Ligand Express

Toronto-based company Cyclica has launched a cloud-based proteome screening platform called Ligand Express. The platform provides users access to the company's AI-assisted, structure-based molecular simulation technology. Users can submit small molecules of interest to rapidly generate unique polypharmacology profiles. These profiles consist of on- and off-target interactions that may be expected, as well as those that are unanticipated, to aid decision making. Off-target interactions can be viewed using the platform's interactive, analytical tools that enable exploration and facilitate deep insights that cannot be gained through traditional target-based approaches.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.